Wei‐Ting Shen
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
-
- Nanoparticle-Based Drug Delivery
Papers in
-
- Nanoplatforms for cancer theranostics 8
- Graphene and Nanomaterials Applications 4
-
- RNA Interference and Gene Delivery 5
- Extracellular vesicles in disease 4
- Co-authors
- Yu‐Chung Liu (1 shared paper)Nai‐Wen Liang (1 shared paper)Yi‐Hsuan Lin (1 shared paper)John J. Hill (1 shared paper)Li‐Han Lin (1 shared paper)James J. Lai (1 shared paper)Joanne Kimiko Liu (1 shared paper)Katalin V. Korpany (1 shared paper)
- Journals
- ACS Nano (3 papers)Nano Letters (2 papers)Advanced Healthcare Materials (1 paper)Journal of Controlled Release (1 paper)The Annual Review of Pharmacology and Toxicology (1 paper)
- Partner nations
- United StatesTaiwanAustralia
In The Last Decade
Wei‐Ting Shen
19 papers receiving 745 citations
Wei‐Ting Shen's Hit Papers
Peers
Comparison fields: 5 of 92
- Cancer Research 181
- Biomaterials 91
- Molecular Biology 458
- Biomedical Engineering 203
- Immunology 69
Countries citing papers authored by Wei‐Ting Shen
This map shows the geographic impact of Wei‐Ting Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐Ting Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐Ting Shen more than expected).
Fields of papers citing papers by Wei‐Ting Shen
This network shows the impact of papers produced by Wei‐Ting Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐Ting Shen. The network helps show where Wei‐Ting Shen may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei‐Ting Shen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Exosome Processing and Characterization Approaches for Research and Technology Development Hit paper breakdown → | 2022 | 445 |
| 2 | 2024 | 50 | |
| 3 | 2011 | 50 | |
| 4 | 2020 | 38 | |
| 5 | 2021 | 34 | |
| 6 | 2024 | 34 | |
| 7 | 2023 | 23 | |
| 8 | 2024 | 17 | |
| 9 | 2023 | 11 | |
| 10 | 2021 | 10 | |
| 11 | 2024 | 9 | |
| 12 | 2020 | 8 | |
| 13 | 2024 | 5 | |
| 14 | 2023 | 4 | |
| 15 | 2025 | 4 | |
| 16 | 2024 | 4 | |
| 17 | 2025 | 4 | |
| 18 | 2025 | 2 | |
| 19 | 2025 | 1 | |
| 20 | 2025 | 0 |
About Wei‐Ting Shen
Wei‐Ting Shen is a scholar working on Biomedical Engineering, Molecular Biology, Biomaterials, Materials Chemistry and Condensed Matter Physics, having authored 23 papers that have together received 753 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (8 papers), Nanoparticle-Based Drug Delivery (5 papers), RNA Interference and Gene Delivery (5 papers), Extracellular vesicles in disease (4 papers), Graphene and Nanomaterials Applications (4 papers), Micro and Nano Robotics (3 papers), Cerebrospinal fluid and hydrocephalus (2 papers) and Metal-Organic Frameworks: Synthesis and Applications (2 papers). The work is most often cited by research in Cancer Research (181 citations), Biomaterials (91 citations), Molecular Biology (458 citations), Biomedical Engineering (203 citations) and Immunology (69 citations). Wei‐Ting Shen has collaborated with scholars based in United States, Taiwan and Australia. Frequent co-authors include Yu‐Chung Liu, Nai‐Wen Liang, Yi‐Hsuan Lin, John J. Hill, Li‐Han Lin, James J. Lai, Joanne Kimiko Liu, Katalin V. Korpany, Liangfang Zhang and Shang‐Hsiu Hu. Their work appears in journals such as ACS Nano, Nano Letters, Advanced Healthcare Materials, Journal of Controlled Release and The Annual Review of Pharmacology and Toxicology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.